{
  "report_rows": [
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.86 vs. cons $2.81",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$3.01B vs. cons $2.97B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~16.7% vs. cons 16.6%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 revenue guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$11.92B vs. cons $11.88B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EPS guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$10.88 vs. cons $10.72 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 operating cash flow guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.75B vs. cons $1.75B (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 3.8,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Predicted FY2026 adjusted EPS guide of ~$10.88 vs. consensus $10.72 implies second-half adjusted EPS of ~$5.52 versus the pre-report consensus implied ~$5.41, supporting modest upward revisions after the initial beat despite the elevated valuation.",
  "day5_confidence": "LOW"
}